在美国,肌痛性骨髓灰质炎的流行病学
Yun Ye1, Dana Jorgensen Murdock2, Chao Chen2
1The Division of Epidemiology, The Ohio State University, Columbus, OH, United States.
Frontiers in neurology
|March 4, 2024
概括
更新的美国数据显示,肌痛性骨髓灰质炎 (MG) 发病率和患病率有所增加,特别是在老年男性中. 这种罕见的自身免疫性疾病影响神经肌肉突触,目前全国约有82,715名成年人受到影响.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 全球研究表明,肌痛性骨髓灰质炎 (MG) 的患病率正在上升,这是一种罕见的自身免疫神经肌肉结合障碍.
- 美国近两十年来一直缺乏最新的流行病学数据.
- 这项研究解决了在美国人口中更新MG的流行率和发病率的需要.
研究的目的:
- 为了估计目前的发生率和发病率的肌痛性肌痛症 (MG) 在一个大,保险的美国人口.
- 为美国提供MG的最新流行病学数据.
- 分析MG发病率和流行率的特定年龄和性别趋势.
主要方法:
- 一项基于人口的回顾性队列研究使用Truven Health MarketScan数据库 (2017) 进行.
- 在商业保险,医疗保险和医疗补助人口中,使用经过验证的算法识别了MG病例.
- 根据年龄和性别标准化估计,计算并推断到2021年美国成年人口.
主要成果:
- 年龄和性别标准化的发病率为68.5个新病例/百万人年,在商业/医疗保险人群中,流行率为316.4个/百万.
- 调整后的发病率为4970万人/年,在医疗补助人口中,患病率为2037万人/年.
- 据估计,2021年约有82,715名美国成年人患有MG,随着年龄的增长和老年人群中男性占优势的转变,患病率越来越高.
结论:
- 更新的美国估计显示,与20年前相比,MG的发病率和流行率增加了.
- 这些发现与工业化国家观察到的趋势一致.
- 随着年龄的增长,特别是老年男性的患病率增加,需要进一步研究基础研究,治疗方法和公共卫生策略.
相关概念视频
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Myasthenia Gravis: Diagnostic Tests
831
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
831
Disorders of the Skeletal Muscle
946
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
946
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Muscle Contraction
6.4K
In skeletal muscles, acetylcholine is released by nerve terminals at the motor endplate—the point of synaptic communication between motor neurons and muscle fibers. The binding of acetylcholine to its receptors on the sarcolemma allows entry of sodium ions into the cell and triggers an action potential in the muscle cell. Thus, electrical signals from the brain are transmitted to the muscle. Subsequently, the enzyme acetylcholinesterase breaks down acetylcholine to prevent excessive...
6.4K
Neuromuscular Junction And Blockade
3.1K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.1K


